Turkish Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 15 out of 15 displayed.

ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results

Read more ››

By: GlobeNewswire - 15 May 2023

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis

Read more ››

By: GlobeNewswire - 12 May 2023

ARS Pharmaceuticals Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on neffy® for the Treatment of Type I Allergic Reactions Including Anaphylaxis

Read more ››

By: GlobeNewswire - 09 May 2023

Jiuzhou Pharmaceutical Welcomes RayHua to Become a Group Member

Read more ››

By: PR Newswire Association LLC. - 26 Apr 2023

GC Genome to Present the Brand New Liquid Biopsy Platform for Cancer Detection at AACR Annual Meeting 2023

Read more ››

By: PR Newswire Association LLC. - 18 Apr 2023

GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications

Read more ››

By: PR Newswire Association LLC. - 12 Apr 2023

GC Genome Announces Publication Demonstrating Feasibility of Liquid Biopsy Technology to Predict Radiation Therapy Response in Solid Tumors

Read more ››

By: PR Newswire Association LLC. - 10 Apr 2023

United Health Products Provides Update on FDA PMA Application Process

Read more ››

By: GlobeNewswire - 29 Mar 2023

ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis

Read more ››

By: GlobeNewswire - 28 Mar 2023

ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

Read more ››

By: GlobeNewswire - 23 Mar 2023

ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

Read more ››

By: GlobeNewswire - 23 Feb 2023

ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

Read more ››

By: GlobeNewswire - 22 Feb 2023

ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

Read more ››

By: GlobeNewswire - 09 Feb 2023

United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement

Read more ››

By: GlobeNewswire - 31 Jan 2023

United Health Products Provides Update on Manufacturing and FDA PMA Application

Read more ››

By: GlobeNewswire - 19 Dec 2022

Looking for companies outside of Turkey?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston

Add an Event »

Latest company news

ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
15 May 2023 (GlobeNewswire)

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
12 May 2023 (GlobeNewswire)

ARS Pharmaceuticals Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on neffy® for the Treatment of Type I Allergic Reactions Including Anaphylaxis
09 May 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Turkish Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com